No Data
No Data
Masimo Urges Shareholders to Support Director Nominees
Masimo (MASI) urged shareholders Thursday to vote for the company's director nominees Joe Kiani and Christopher Chavez.The company said actions taken by investor Politan Capital Management and its
Masimo Exposes Politan's Governance Hypocrisy, Says "Over The Past Twelve Months, We Believe Politan's Quentin Koffey Has Repeatedly Acted Against The Best Interests Of Masimo And Its Stockholders"
Highlights Quentin Koffey's Actions That Have Flown in the Face of Good GovernanceMasimo Corporation ("Masimo" or the "Company") (NASDAQ:MASI) today highlighted the actions taken by Politan and
Is Masimo (NASDAQ:MASI) Using Too Much Debt?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' It's only natural to
Masimo (MASI) Preliminary Q2 Results Aided by Healthcare Unit
Needham Maintains Masimo(MASI.US) With Hold Rating
Needham analyst Michael Matson maintains $Masimo(MASI.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 41.8% and a total average return of -7.2% over the past
What's Going On With Health Technology Company Masimo Shares Today?
Masimo Corporation (NASDAQ:MASI) shares are trading lower on Tuesday.Yesterday, Masimo reportedly disclosed that a potential joint venture partner is poised to bid between $850 million and $950